- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare SBI Healthcare Opportunities Fund vs UTI Healthcare Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 5.0 | 4.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 1.93 | 2.27 |
NAV | ₹417.66 | ₹278.84 |
Fund Started | 04 Jun 1999 | 01 Aug 2005 |
Fund Size | ₹3689.28 Cr | ₹1062.19 Cr |
Exit Load | Exit load of 0.50% if redeemed within 15 days | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
5.0
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
1.93
2.27
NAV
₹417.66
₹278.84
Fund Started
04 Jun 1999
01 Aug 2005
Fund Size
₹3689.28 Cr
₹1062.19 Cr
Exit Load
Exit load of 0.50% if redeemed within 15 days
Exit load of 1% if redeemed within 30 days.
Returns
1 Year | 17.30% | 18.63% |
3 Year | 28.86% | 26.98% |
5 Year | 23.38% | 21.52% |
1 Year
17.30%
18.63%
3 Year
28.86%
26.98%
5 Year
23.38%
21.52%
Holding Analysis
Equity | 96.09% | 97.33% |
Cash | 3.83% | 2.66% |
Equity
96.09%
97.33%
Cash
3.83%
2.66%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.73% |
Divi's Laboratories Ltd. | 7.39% |
Max Healthcare Institute Ltd. | 6.40% |
Lonza Group Ag | 4.81% |
Cipla Ltd. | 4.77% |
Lupin Ltd. | 4.46% |
Mankind Pharma Ltd. | 3.75% |
Krishna Institute of Medical Sciences Ltd | 3.34% |
Fortis Healthcare Ltd. | 3.22% |
Acutaas Chemicals Ltd. | 3.19% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.44% |
Cipla Ltd. | 5.52% |
Dr. Reddy's Laboratories Ltd. | 4.66% |
Procter & Gamble Health Ltd. | 4.34% |
Ajanta Pharma Ltd. | 4.09% |
Glenmark Pharmaceuticals Ltd. | 3.78% |
Apollo Hospitals Enterprise Ltd. | 3.65% |
Divi's Laboratories Ltd. | 3.49% |
Fortis Healthcare Ltd. | 3.09% |
Eris Lifesciences Ltd. | 3.04% |
Fund Manager
Name | Tanmaya Desai | Kamal Gada |
Start Date | 27 Jun 2011 | 02 May 2022 |
Name
Tanmaya Desai
Kamal Gada
Start Date
27 Jun 2011
02 May 2022
About Fund
Description | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 04 Jun 1999 | 01 Aug 2005 |
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
04 Jun 1999
01 Aug 2005
